BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8832988)

  • 1. Fatigue in ankylosing spondylitis: its prevalence and relationship to disease activity, sleep, and other factors.
    Jones SD; Koh WH; Steiner A; Garrett SL; Calin A
    J Rheumatol; 1996 Mar; 23(3):487-90. PubMed ID: 8832988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinimetric evaluation of the bath ankylosing spondylitis metrology index in a controlled trial of pamidronate therapy.
    Jauregui E; Conner-Spady B; Russell AS; Maksymowych WP
    J Rheumatol; 2004 Dec; 31(12):2422-8. PubMed ID: 15570645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatigue in patients with ankylosing spondylitis: A comparison with the general population and associations with clinical and self-reported measures.
    Dagfinrud H; Vollestad NK; Loge JH; Kvien TK; Mengshoel AM
    Arthritis Rheum; 2005 Feb; 53(1):5-11. PubMed ID: 15696569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.
    Calin A; Garrett S; Whitelock H; Kennedy LG; O'Hea J; Mallorie P; Jenkinson T
    J Rheumatol; 1994 Dec; 21(12):2281-5. PubMed ID: 7699629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mental health status and leisure-time physical activity contribute to fatigue intensity in patients with spondylarthropathy.
    Da Costa D; Dritsa M; Ring A; Fitzcharles MA
    Arthritis Rheum; 2004 Dec; 51(6):1004-8. PubMed ID: 15593104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation and validation of the patient acceptable symptom state (PASS) in patients with ankylosing spondylitis.
    Maksymowych WP; Richardson R; Mallon C; van der Heijde D; Boonen A
    Arthritis Rheum; 2007 Feb; 57(1):133-9. PubMed ID: 17266072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring disease activity in ankylosing spondylitis: patient and physician have different perspectives.
    Spoorenberg A; van Tubergen A; Landewé R; Dougados M; van der Linden S; Mielants H; van de Tempel H; van der Heijde D
    Rheumatology (Oxford); 2005 Jun; 44(6):789-95. PubMed ID: 15757962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of fatigue in the management of patients with ankylosing spondylitis.
    Dernis-Labous E; Messow M; Dougados M
    Rheumatology (Oxford); 2003 Dec; 42(12):1523-8. PubMed ID: 13130145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Work status among patients with ankylosing spondylitis in Argentina.
    Marengo MF; Schneeberger EE; Citera G; Cocco JA
    J Clin Rheumatol; 2008 Oct; 14(5):273-7. PubMed ID: 18679137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring disability in ankylosing spondylitis: comparison of bath ankylosing spondylitis functional index with revised Leeds Disability Questionnaire.
    Eyres S; Tennant A; Kay L; Waxman R; Helliwell PS
    J Rheumatol; 2002 May; 29(5):979-86. PubMed ID: 12022361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatigue in ankylosing spondylitis.
    Missaoui B; Revel M
    Ann Readapt Med Phys; 2006 Jul; 49(6):305-8, 389-91. PubMed ID: 16780989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A longitudinal study of disease activity and functional status in a hospital cohort of patients with ankylosing spondylitis.
    Robertson LP; Davis MJ
    Rheumatology (Oxford); 2004 Dec; 43(12):1565-8. PubMed ID: 15353608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatigue in ankylosing spondylitis--why is it ignored?
    Calin A; Edmunds L; Kennedy LG
    J Rheumatol; 1993 Jun; 20(6):991-5. PubMed ID: 8350337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in hemoglobin levels in patients with ankylosing spondylitis treated with infliximab.
    Braun J; van der Heijde D; Doyle MK; Han C; Deodhar A; Inman R; de Vlam K; Burmester GR; Van den Bosch F; Xu S; Visvanathan S; Rahman MU
    Arthritis Rheum; 2009 Aug; 61(8):1032-6. PubMed ID: 19644896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The unmet need for anti-tumour necrosis factor (anti-TNF) therapy in ankylosing spondylitis.
    Barkham N; Kong KO; Tennant A; Fraser A; Hensor E; Keenan AM; Emery P
    Rheumatology (Oxford); 2005 Oct; 44(10):1277-81. PubMed ID: 16105913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease and psychological status in ankylosing spondylitis.
    Martindale J; Smith J; Sutton CJ; Grennan D; Goodacre L; Goodacre JA
    Rheumatology (Oxford); 2006 Oct; 45(10):1288-93. PubMed ID: 16595514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary evaluation of a visual analog function scale for use in rheumatoid arthritis.
    Wolfe F; Michaud K; Pincus T
    J Rheumatol; 2005 Jul; 32(7):1261-6. PubMed ID: 15996062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of peripheral arthritis on disease activity in ankylosing spondylitis patients as measured with the Bath Ankylosing Spondylitis Disease Activity Index.
    Heuft-Dorenbosch L; van Tubergen A; Spoorenberg A; Landewé R; Dougados M; Mielants H; van der Tempel H; van der Heijde D
    Arthritis Rheum; 2004 Apr; 51(2):154-9. PubMed ID: 15077254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sociodemographic, disease, and symptom correlates of fatigue in systemic sclerosis: evidence from a sample of 659 Canadian Scleroderma Research Group Registry patients.
    Thombs BD; Hudson M; Bassel M; Taillefer SS; Baron M;
    Arthritis Rheum; 2009 Jul; 61(7):966-73. PubMed ID: 19565539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is disease severity in ankylosing spondylitis genetically determined?
    Hamersma J; Cardon LR; Bradbury L; Brophy S; van der Horst-Bruinsma I; Calin A; Brown MA
    Arthritis Rheum; 2001 Jun; 44(6):1396-400. PubMed ID: 11407700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.